GMAB Competitors & Alternatives
Compare Genmab AS with similar stocks in the same industry
Biotechnology
GMAB
Main Stock$28.68
Tradestie Score
52
Market Cap
$19.56B
P/E Ratio
21.9
Revenue Growth
0.3%
Analyst Upside
+32.4%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BNTX
BioNTech SE American Depositary Share
|
$92.25
|
$24.57B | - | 56 | Compare |
|
INCY
Incyte Genomics Inc
|
$118.43
|
$16.93B | 15.2 | 54 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.17
|
$15.70B | 30.8 | 54 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.05
|
$15.22B | - | 53 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$243.45
|
$12.36B | 28.1 | 54 | Compare |
|
EXEL
Exelixis Inc
|
$55.06
|
$11.09B | 17.6 | 47 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$33.32
|
$10.76B | - | 56 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$55.14
|
$10.74B | - | 51 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$60.00
|
$10.53B | 43.2 | 56 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$54.49
|
$10.49B | - | 59 | Compare |
More GMAB Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry